研究表明荷尔蒙疗法降低了变性成年人的抑郁风险,但获得治疗的问题依然存在。 Study shows hormone therapy lowers depression risk for transgender adults, but access issues persist.

JAMA网络开放的一项新研究表明,接受确认性别的荷尔蒙疗法的变性成年人在4年中患中度至严重抑郁的风险比未接受这种治疗的成人低15%。 A new study in JAMA Network Open shows that transgender adults receiving gender-affirming hormone therapy had a 15% lower risk of moderate-to-severe depression over four years compared to those who did not receive such care. 这项研究跟踪了3 592名变性人、非二进制人和具有性别差异的成年人,强调荷尔蒙疗法对心理健康的好处。 The research, which tracked 3,592 transgender, nonbinary, and gender-diverse adults, underscores the mental health benefits of hormone therapy. 然而,研究还警告说,由于各州的法律,这些社区心理健康差距的恶化,获得这种护理越来越困难。 However, the study also warns that access to this care is becoming increasingly difficult due to state laws, worsening mental health disparities in these communities.